Synthesis of MDM2 Inhibitors to Reactivate p53 Function
Cancer is arise by inhibition of cell killing apoptosis process. Specific protein–protein interaction is responsible for the inhibition of apoptosis in the body. In this study, novel heterocyclic compounds (1,3,4-thiadiazole based) were synthesized. Synthesized compounds were successfully characterized by physical and spectral methods. And biological activity of the synthesized compounds was evaluated by cell-based assays. MTT assay was performed to determine the anti-neoplastic activity of the synthesized compounds. Moreover, a potency of the synthesized compounds was derived by IC50 value. In an assay (in vitro), the synthesized compound induced the apoptosis in the cancer cell line. Hence, it will be proven as a potential anticancer agent.
How to Cite
Copyright (c) 2023 Chirag J. Gohil
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.